AVANT DIAGNOSTICS INC Inactive Instrument
Company Avant Diagnostics Inc
Equities
US05350M1062
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2021 | Avant Diagnostics : AvidXchange Shares Fall in Trading Debut | MT |
| 2021 | Avant Diagnostics : AvidXchange Prices IPO at $25 Per Share | MT |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Ruxin
CEO | Chief Executive Officer | 78 | 30/11/17 |
Thomas Chilcott
DFI | Director of Finance/CFO | 56 | 23/09/20 |
Glenn D. Hoke
CTO | Chief Tech/Sci/R&D Officer | - | 11/05/16 |
Trevor McCartney
PRN | Corporate Officer/Principal | - | 28/02/19 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 24/05/18 |
Michael Ruxin
CEO | Chief Executive Officer | 78 | 30/11/17 |
| Director/Board Member | 43 | - | |
| 51 | - | ||
Yvonne Fors
BRD | Director/Board Member | 52 | 31/12/99 |
Matthew Schwartz
BRD | Director/Board Member | 50 | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 336,957,722 | 9,119,130 ( 2.706 %) | 0 | 2.706 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
THERALINK TECHNOLOGIES, INC. 100.00% | 1,000 | 100.00% | 1 $ |
Company contact information
Theralink Technologies, Inc. (Colorado)
15000 West 6th Avenue Suite 400
80401, Golden
+
https://theralink.com
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -31.90% | 9.59B | |
| -6.25% | 3.21B | |
| +25.95% | 2.92B | |
| -13.96% | 2.15B | |
| -16.83% | 1.79B | |
| +72.82% | 1.47B | |
| +29.17% | 770M | |
| -2.62% | 761M | |
| -26.33% | 548M |
- Stock Market
- Equities
- Stock
- Company Avant Diagnostics Inc
